A study by Oxford University found that the number of people who receive blood clots after being vaccinated with a coronavirus vaccine is about the same for those who receive Pfizer PFE,
and Modern MRNA,
vaccines as they are for AstraZeneca AZN,
vaccine that was produced with the help of the university. According to the study, 4 out of 1 million people suffer from cerebral venous thrombosis after receiving the Pfizer or Moderna vaccine, compared to 5 out of 1 million people for the AstraZeneca vaccine. The risk of having CVD is much higher for those receiving COVID-19-39 per million patients – than for those receiving vaccination. The use of the AstraZeneca vaccine has been stopped or restricted in many countries due to concerns about blood clots.